26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

sarcoma 636 scavenger receptors<br />

Open lung biopsy showing sarcoidosis.<br />

geographically in the southeastern United States. It exhibits<br />

a decrease in circulating T cells. Decreased delayedtype<br />

hypersensitivity is manifested as anergy to common<br />

skin test antigens. Increased antibody formation leads to<br />

polyclonal hypergammaglobulinemia. A marked cellular<br />

immune response is observed in local areas of disease activity.<br />

Tissue lesions consist of inflammatory cells and granulomas<br />

composed of activated mononuclear phagocytes such<br />

as epithelioid cells, multinucleated giant cells, and macrophages.<br />

Activated T cells are present at the periphery of<br />

the granuloma. CD4 + T cells appear to be the immunoregulatory<br />

agents governing granuloma formation. Mediators<br />

released from T cells nonspecifically stimulate B cells,<br />

resulting in the polyclonal hypergammaglobulinemia. The<br />

granulomas are typically noncaseating, distinguishing them<br />

from those produced in tuberculosis. Patients may develop<br />

fever, polyarthritis, erythema nodosum, and iritis. They also<br />

may experience loss of weight, anorexia, weakness, fever,<br />

sweats, nonproductive cough, and increasing dyspnea on<br />

exertion. Pulmonary symptoms occur in more than 90% of<br />

patients. Angiotensin-converting enzyme is increased in the<br />

sera of sarcoid patients. Disease activity is monitored by<br />

measuring the level of this enzyme in serum. The subcutaneous<br />

inoculation of sarcoidosis lymph node extracts into<br />

patients diagnosed with sarcoidosis leads to a granulomatous<br />

reaction in the skin 3 to 4 weeks after inoculation. This<br />

served as a diagnostic test of questionable value (known<br />

as the Kveim reaction) in the past. Sarcoidosis symptoms<br />

can be treated with corticosteroids, but only after disease<br />

progression occurs. Sarcoidosis is a relatively mild disease,<br />

with 80% of cases resolving spontaneously and only 5%<br />

dying of complications. Evidence indicates oligoclonal<br />

expansion of αβ T cell subsets and predominant expression<br />

of type 1 cytokines—interferon-γ (IFN-γ) and interleukin-2<br />

(IL1-2)—at sites of inflammation, suggesting that sarcoidosis<br />

is an antigen-driven, Th1-mediated immune disorder.<br />

sarcoma<br />

A malignant neoplasm arising from connective tissue cells<br />

including muscle, bone or cartilage.<br />

Sca-1<br />

Abbreviation for stem cell antigen 1.<br />

SCABs (single-chain antigen-binding proteins)<br />

Polypeptides that join the light chain variable sequence of<br />

an antibody to the heavy chain variable sequence of the<br />

antibody. All monoclonal antibodies are potential sources<br />

of SCABs. They are smaller and less immunogenic than<br />

intact heavy chains with immunogenic constant regions.<br />

Their potential uses include imaging and treatment of<br />

cancer, in cardiovascular disease, as biosensors, and for<br />

chemical separations.<br />

scarlet fever<br />

A condition associated with production of erythrogenic<br />

toxin by group A hemolytic streptococci associated with<br />

pharyngitis. Patients develop strawberry-red tongues and<br />

generalized erythematous blanching areas that do not occur<br />

on the palms, the soles of the feet, or in the mouth. They<br />

may also develop Pastia’s lines (petechiae in linear patterns).<br />

Scatchard analysis<br />

A mathematical analytical method to determine the affinity<br />

and valence of a receptor–ligand interaction in equilibrium<br />

binding.<br />

Scatchard equation<br />

An expression for the union of a univalent ligand with an<br />

antibody molecule (r/c = Kn – Kr). To obtain the average<br />

number of ligand molecules to which an antibody molecule<br />

may bind at equilibrium, the bound ligand molar<br />

concentration is divided by the antibody molar concentration<br />

designated as r. The free ligand molar concentration is<br />

represented by c; antibody valence by n; and the association<br />

constant by K.<br />

d<br />

(Ag)<br />

d<br />

d<br />

(Ag)<br />

Scatchard plot<br />

A graphic representation of binding data obtained by<br />

plotting r/c against r (refer to Scatchard equation). The<br />

purpose of this plot is to determine intrinsic association<br />

constants and ascertain how many noninteracting binding<br />

sites each molecule contains. A straight line with a slope of<br />

–K indicates that all the binding sites are the same and are<br />

independent. The plot should also intercept on the r axis of<br />

n. A nonlinear plot signifies that the binding sites are not<br />

the same and are not independent. The degree to which the<br />

sites are occupied is reflected by the slope (–K). An average<br />

association constant for ligand binding to heterogeneous<br />

antibodies is the reciprocal of the amount of free ligand<br />

needed for half saturation of antibody sites.<br />

scavenger receptors<br />

Structures on macrophages and other cell types that<br />

bind a variety of ligands and delete them from the blood.<br />

Scavenger receptors are especially abundant on Kupffer’s<br />

cells of the liver.<br />

d<br />

Scatchard plot.<br />

=–K<br />

x - intercept

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!